Wird geladen …
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial
The relationship between baseline fasting C‐peptide (FCP) and glucose control was examined in insulin‐naïve people with type 2 diabetes inadequately controlled with oral antihyperglycaemic drugs commencing basal insulin glargine 300 U/mL (Gla‐300) or 100 U/mL (Gla‐100) in the absence of sulfonylurea...
Hauptverfasser: | , , , , |
---|---|
Format: | Online Artikel Text |
Sprache: | English |
Veröffentlicht: |
Blackwell Publishing Ltd
2020
|
Schlagworte: | |
Online Zugang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496109/ https://www.ncbi.nlm.nih.gov/pubmed/32314521 http://dx.doi.org/10.1111/dom.14065 |